Additional file 1: of Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study

Figure S1. Kaplanâ Meier survival curve for maintaining bDMARD-free remission after discontinuation of each bDMARD. X axis represents days after bDMARD discontinuation. Y axis represents rates of maintained BFR. bDMARD biological disease-modifying anti-rheumatic drug, BFR biological disease-modifying anti-rheumatic drug-free remission, ABT abatacept, ADA adalimumab, CZP certolizumab, ETN etanercept, GLM golimumab, IFX infliximab, TCZ tocilizumab (PDF 80Â kb) (PDF 79 kb)